Nanotechnology and Tumor Imaging: Seizing an Opportunity

Nanoparticles, labeled with a signaling moiety for in vivo imaging, and one or more ligands for molecularly targeted specificity, hold considerable promise in oncology. Nanoparticles can serve as modular platforms, from which a wide variety of highly sensitive and specific imaging agents can be crea...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel C. Sullivan, Mauro Ferrari
Format: Article
Language:English
Published: SAGE Publishing 2004-10-01
Series:Molecular Imaging
Online Access:https://doi.org/10.1162/15353500200404139
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841564578384707584
author Daniel C. Sullivan
Mauro Ferrari
author_facet Daniel C. Sullivan
Mauro Ferrari
author_sort Daniel C. Sullivan
collection DOAJ
description Nanoparticles, labeled with a signaling moiety for in vivo imaging, and one or more ligands for molecularly targeted specificity, hold considerable promise in oncology. Nanoparticles can serve as modular platforms, from which a wide variety of highly sensitive and specific imaging agents can be created. For example, many hundreds or thousands of atoms that provide imaging signals, such as radioisotopes, lanthanides, or fluorophores, can be attached to each nanoparticle, to form imaging agents that would provide higher sensitivity that can be obtained from agents based on small molecules. Similarly, many copies of targeted ligands can be attached to nanoparticles to markedly inrease specific binding. Drugs or therapeutic isotopes can be added to create multifunctional nanoparticles. Appropriately labeled and targeted nanoparticles could lead to a paradigm change in which cancer detection, diagnosis, and therapy are combined in a single molecular complex.
format Article
id doaj-art-bac8c31e171a42428a98bf30fc0932db
institution Kabale University
issn 1536-0121
language English
publishDate 2004-10-01
publisher SAGE Publishing
record_format Article
series Molecular Imaging
spelling doaj-art-bac8c31e171a42428a98bf30fc0932db2025-01-02T22:37:25ZengSAGE PublishingMolecular Imaging1536-01212004-10-01310.1162/1535350020040413910.1162_15353500200404139Nanotechnology and Tumor Imaging: Seizing an OpportunityDaniel C. Sullivan0Mauro Ferrari1National Cancer InstituteThe Ohio State UniversityNanoparticles, labeled with a signaling moiety for in vivo imaging, and one or more ligands for molecularly targeted specificity, hold considerable promise in oncology. Nanoparticles can serve as modular platforms, from which a wide variety of highly sensitive and specific imaging agents can be created. For example, many hundreds or thousands of atoms that provide imaging signals, such as radioisotopes, lanthanides, or fluorophores, can be attached to each nanoparticle, to form imaging agents that would provide higher sensitivity that can be obtained from agents based on small molecules. Similarly, many copies of targeted ligands can be attached to nanoparticles to markedly inrease specific binding. Drugs or therapeutic isotopes can be added to create multifunctional nanoparticles. Appropriately labeled and targeted nanoparticles could lead to a paradigm change in which cancer detection, diagnosis, and therapy are combined in a single molecular complex.https://doi.org/10.1162/15353500200404139
spellingShingle Daniel C. Sullivan
Mauro Ferrari
Nanotechnology and Tumor Imaging: Seizing an Opportunity
Molecular Imaging
title Nanotechnology and Tumor Imaging: Seizing an Opportunity
title_full Nanotechnology and Tumor Imaging: Seizing an Opportunity
title_fullStr Nanotechnology and Tumor Imaging: Seizing an Opportunity
title_full_unstemmed Nanotechnology and Tumor Imaging: Seizing an Opportunity
title_short Nanotechnology and Tumor Imaging: Seizing an Opportunity
title_sort nanotechnology and tumor imaging seizing an opportunity
url https://doi.org/10.1162/15353500200404139
work_keys_str_mv AT danielcsullivan nanotechnologyandtumorimagingseizinganopportunity
AT mauroferrari nanotechnologyandtumorimagingseizinganopportunity